Cargando…

Hypercholesterolemia affects cardiac function, infarct size and inflammation in APOE*3-Leiden mice following myocardial ischemia-reperfusion injury

BACKGROUND: Hypercholesterolemia is a major risk factor for ischemic heart disease including acute myocardial infarction. However, long-term effects of hypercholesterolemia in a rodent myocardial ischemia-reperfusion injury model are unknown. Therefore, the effects of diet-induced hypercholesterolem...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pluijmert, Niek J., den Haan, Melina C., van Zuylen, Vanessa L., Steendijk, Paul, de Boer, Hetty C., van Zonneveld, Anton J., Fibbe, Willem E., Schalij, Martin J., Quax, Paul H. A., Atsma, Douwe E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6570022/ https://www.ncbi.nlm.nih.gov/pubmed/31199833 http://dx.doi.org/10.1371/journal.pone.0217582

Ejemplares similares

Effects on cardiac function, remodeling and inflammation following myocardial ischemia–reperfusion injury or unreperfused myocardial infarction in hypercholesterolemic APOE*3-Leiden mice
por: Pluijmert, Niek J., et al.
Publicado: (2020)

Discrepant Results of Experimental Human Mesenchymal Stromal Cell Therapy after Myocardial Infarction: Are Animal Models Robust Enough?
por: den Haan, Melina C., et al.
Publicado: (2016)

Myocardial infarction models in NOD/Scid mice for cell therapy research: permanent ischemia vs ischemia–reperfusion
por: van Zuylen, Vanessa-Leigh, et al.
Publicado: (2015)

Post-ischemic Myocardial Inflammatory Response: A Complex and Dynamic Process Susceptible to Immunomodulatory Therapies
por: Pluijmert, Niek J., et al.
Publicado: (2021)

Annexin A5 reduces infarct size and improves cardiac function after myocardial ischemia-reperfusion injury by suppression of the cardiac inflammatory response
por: de Jong, Rob C. M., et al.
Publicado: (2018)

The Prebiotic Inulin Aggravates Accelerated Atherosclerosis in Hypercholesterolemic APOE*3-Leiden Mice
por: Hoving, Lisa R., et al.
Publicado: (2018)

Phosphorylcholine Antibodies Preserve Cardiac Function and Reduce Infarct Size by Attenuating the Post-Ischemic Inflammatory Response
por: Pluijmert, Niek J., et al.
Publicado: (2020)

Phosphorylcholine antibodies restrict infarct size and left ventricular remodelling by attenuating the unreperfused post‐ischaemic inflammatory response
por: Pluijmert, Niek J., et al.
Publicado: (2021)

Cardiomyogenic differentiation-independent improvement of cardiac function by human cardiomyocyte progenitor cell injection in ischaemic mouse hearts
por: den Haan, Melina C, et al.
Publicado: (2012)

bFGF blockade reduces intraplaque angiogenesis and macrophage infiltration in atherosclerotic vein graft lesions in ApoE3*Leiden mice
por: Parma, Laura, et al.
Publicado: (2020)

Prolonged Hyperoxygenation Treatment Improves Vein Graft Patency and Decreases Macrophage Content in Atherosclerotic Lesions in ApoE3*Leiden Mice
por: Parma, Laura, et al.
Publicado: (2020)

Akkermansia muciniphila Exerts Lipid‐Lowering and Immunomodulatory Effects without Affecting Neointima Formation in Hyperlipidemic APOE*3‐Leiden.CETP Mice
por: Katiraei, Saeed, et al.
Publicado: (2019)

Atherothrombosis model by silencing of protein C in APOE*3-Leiden.CETP transgenic mice
por: Jongejan, Yvonne K., et al.
Publicado: (2021)

Cannabinoid type 1 receptor inverse agonism attenuates dyslipidemia and atherosclerosis in APOE∗3-Leiden.CETP mice
por: van Eenige, Robin, et al.
Publicado: (2021)

Continuous Light Does Not Affect Atherosclerosis in APOE*3-Leiden.CETP Mice
por: Schilperoort, Maaike, et al.
Publicado: (2020)

P300/CBP Associated Factor (PCAF) Deficiency Enhances Diet-Induced Atherosclerosis in ApoE3(*)Leiden Mice via Systemic Inhibition of Regulatory T Cells
por: de Jong, Alwin, et al.
Publicado: (2021)

Novel Approaches to Treat Experimental Pulmonary Arterial Hypertension: A Review
por: Umar, S., et al.
Publicado: (2010)

Dose Effects of Ammonium Perfluorooctanoate on Lipoprotein Metabolism in APOE*3-Leiden.CETP Mice
por: Pouwer, Marianne G, et al.
Publicado: (2019)

Combined GIP receptor and GLP1 receptor agonism attenuates NAFLD in male APOE∗3-Leiden.CETP mice
por: Ying, Zhixiong, et al.
Publicado: (2023)

Niacin Reduces Atherosclerosis Development in APOE*3Leiden.CETP Mice Mainly by Reducing NonHDL-Cholesterol
por: Kühnast, Susan, et al.
Publicado: (2013)

Plasma and Liver Lipidomics Response to an Intervention of Rimonabant in ApoE*3Leiden.CETP Transgenic Mice
por: Hu, Chunxiu, et al.
Publicado: (2011)

Atorvastatin Attenuates Diet-Induced Non-Alcoholic Steatohepatitis in APOE*3-Leiden Mice by Reducing Hepatic Inflammation
por: Inia, José A., et al.
Publicado: (2023)

Oncostatin M reduces atherosclerosis development in APOE*3Leiden.CETP mice and is associated with increased survival probability in humans
por: van Keulen, Danielle, et al.
Publicado: (2019)

Inflammatory cytokine oncostatin M induces endothelial activation in macro- and microvascular endothelial cells and in APOE*3Leiden.CETP mice
por: van Keulen, Danielle, et al.
Publicado: (2018)

The Effect of PPE-Induced Emphysema and Chronic LPS-Induced Pulmonary Inflammation on Atherosclerosis Development in APOE*3-LEIDEN Mice
por: Khedoe, P. Padmini S. J, et al.
Publicado: (2013)

The prebiotic inulin modulates gut microbiota but does not ameliorate atherosclerosis in hypercholesterolemic APOE*3-Leiden.CETP mice
por: Hoving, Lisa R., et al.
Publicado: (2018)

A Systems Analysis of Phenotype Heterogeneity in APOE*3Leiden.CETP Mice Induced by Long-Term High-Fat High-Cholesterol Diet Feeding
por: Paalvast, Yared, et al.
Publicado: (2022)

Disruption of circadian rhythm by alternating light‐dark cycles aggravates atherosclerosis development in APOE*3‐Leiden.CETP mice
por: Schilperoort, Maaike, et al.
Publicado: (2019)

History and highlights of the teratological collection in the Museum Anatomicum of Leiden University, The Netherlands
por: Boer, Lucas L., et al.
Publicado: (2018)

E-health bij poliklinische follow-up van myocardinfarctpatiënten
por: Treskes, Roderick, et al.
Publicado: (2020)

The APOE(∗)3-Leiden Heterozygous Glucokinase Knockout Mouse as Novel Translational Disease Model for Type 2 Diabetes, Dyslipidemia, and Diabetic Atherosclerosis
por: Pouwer, Marianne G., et al.
Publicado: (2019)

Time-restricted feeding attenuates hypercholesterolaemia and atherosclerosis development during circadian disturbance in APOE∗3-Leiden.CETP mice
por: In Het Panhuis, Wietse, et al.
Publicado: (2023)

Intramyocardial Injection of Autologous Bone Marrow-Derived Ex Vivo Expanded Mesenchymal Stem Cells in Acute Myocardial Infarction Patients is Feasible and Safe up to 5 Years of Follow-up
por: Rodrigo, Sander F., et al.
Publicado: (2013)

Multiple aspects of lymphatic dysfunction in an ApoE ( −/− ) mouse model of hypercholesterolemia
por: Davis, Michael J., et al.
Publicado: (2023)

Anti-PCSK9 antibodies inhibit pro-atherogenic mechanisms in APOE*3Leiden.CETP mice
por: Schuster, Susanne, et al.
Publicado: (2019)

Lipidomics Reveals Multiple Pathway Effects of a Multi-Components Preparation on Lipid Biochemistry in ApoE*3Leiden.CETP Mice
por: Wei, Heng, et al.
Publicado: (2012)

Mobile health for cardiovascular risk management after cardiac surgery: results of a sub-analysis of The Box 2.0 study
por: Biersteker, Tommas Evan, et al.
Publicado: (2023)

Bone Marrow Cell Injection for Chronic Myocardial Ischemia: The Past and the Future
por: van Ramshorst, Jan, et al.
Publicado: (2011)

No substantial excess all-cause mortality among cardiac implantable electronic device patients during the first COVID‑19 lockdown in the Leiden area
por: Feijen, M., et al.
Publicado: (2022)

The Leiden Convention coronary coding system: translation from the surgical to the universal view
por: Koppel, Claire J, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_2m0j0vcc7905ud4qf8mfubcgnm